Overview Fundamentals API Earnings EOD API Sample Code Pricing

BioLineRx Ltd (BLRX NASDAQ) stock market data APIs

$0.7856 -0.04(-4.8%) as of July 19, 2024
Price chart is built with Anychart

BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It also develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.

BioLineRx Ltd Financial Data Overview

66 350 K
79 939 K
11 655 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'BLRX',
Type: 'Common Stock',
Name: 'BioLineRx Ltd',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG001Y26LK0',
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: '2011-07-25',
InternationalDomestic: 'International/Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'ADR',
IsDelisted: false,

BioLineRx Ltd Fundamental Data is available in our Financial Data APIs

  • Net Revenue 11 655 K
  • EBITDA -37 500 000
  • Earnings Per Share -0.76
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get BioLineRx Ltd Earnings via APIs

  • Latest Release 2024-05-28
  • EPS/Forecast -0.29

Get BioLineRx Ltd End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?